James J. Vaughn

James J. Vaughn discloses dealings in Genomic Health Inc to SEC (Form 4). We count 136 filings; the first trade dates from 7 December 2015 and the latest from 8 November 2019.

Every open-market trade on record is a sale: 80 sales worth €10.4M. Besides market trades, the filings include 8 share grants and 46 option exercises. 2019 to date brings no purchases and 40 sales.

Most recently, on 14 November 2019, the filings show a transaction in Genomic Health Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.